Open Access Open Access  Restricted Access Subscription Access

Advancements in Artificial Heart Technology and Etiology, Pathophysiology, Diagnosis, Differential Diagnosis, Treatment as well as Complications of Cardiovascular Diseases

Dr. G. Sri Manjula, Ramanjaneyulu D. V., Muralinath E., Guruprasad M., Sravani Pragna K., Manjari P., Sony Sharlet E., T. Nikhil, V. Yaswanth Sai, D. Kusuma Latha, R. Faith Rani, P. Megha Varna

Abstract


In recent years, the field of Cardiovascular medicine has witnessed groundbreaking advancements in artificial heart technology. Early iterations of artificial hearts faced significant challenges, along with issues related to biocompatibility, durability and size. One notable example of a breakthrough in artificial hear technology is the development of Syncardia temporary Total Artificial Heart (TAH), which received FDA approval in 2004. Moreover, advancements in materials science and biocompatible coatings have contributed to the development of artificial hearts with improved longevity and reduced risk of complications, such as thrombosis and infection. Finally, it is concluded that artificial hearts represents a paradigm shift in the treatment of Cardio vascular disease, offering hope to individuals with end _ stage heart failure who would otherwise face limited options for survival.


Full Text:

PDF

References


Chiang, Y. P., Chikwe, J., Moskowitz, A. J., Itagaki, S., Adams, D. H., & Egorova, N. N. (2014). Survival and long-term outcome following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years. JAMA, 312(13), 1323-1329. https://doi.org/10.1001/jama.2014.12528

O’Riordan, M. (2013). SCCT policy statement recommends CT prior to TAVI/TAVR procedures. Medscape Medical News. Retrieved January 11, 2013, from https://www.medscape.com/viewarticle/777125

Achenbach, S., Delgado, V., Hausleiter, J., Schoenhagen, P., Min, J. K., & Leipsic, J. A. (2012). SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). Journal of Cardiovascular Computed Tomography, 6(6), 366-380. https://doi.org/10.1016/j.jcct.2012.08.001

Whitlock, R. P., Sun, J. C., Fremes, S. E., Rubens, F. D., & Teoh, K. H. (2012). Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141(2 Suppl), e576S-e600S. https://doi.org/10.1378/chest.11-2299

iData Research. (2020). Over 182,000 heart valve replacements per year in the United States. Retrieved November 11, 2020, from https://idataresearch.com/over-182000-heart-valve-replacements-per-year-in-the-united-states/

Mahmaljy, H., Tawney, A., & Young, M. (2020). Transcatheter aortic valve replacement. In StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK556059/

Mack, M. J., Leon, M. B., Thourani, V. H., et al. (2019). Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. New England Journal of Medicine, 380(18), 1695-1705. https://doi.org/10.1056/NEJMoa1901082

U.S. Food and Drug Administration. (2019). FDA expands indication for several transcatheter heart valves to patients at low risk for death or major complications associated with open-heart surgery. Retrieved August 16, 2019, from https://www.fda.gov/news-events/press-announcements/fda-expands-indication-several-transcatheter-heart-valves-patients-low-risk-death-or-major

Rahimtoola, S. H. (2010). Choice of prosthetic heart valve in adults: An update. Journal of the American College of Cardiology, 55(22), 2413-2426. https://doi.org/10.1016/j.jacc.2010.01.014

Farley, A., McLafferty, E., & Hendry, C. (2012). The cardiovascular system. Nursing Standard, 27(9), 35-39. https://doi.org/10.7748/ns2012.10.27.9.35.c9256

Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., de Ferranti, S. D., Ferguson, J. F., Fornage, M., Gillespie, C., Isasi, C. R., Jiménez, M. C., Jordan, L. C., Judd, S. E., Lackland, D., Lichtman, J. H., Lisabeth, L., Liu, S., Longenecker, C. T., Lutsey, P. L., Mackey, J. S., Matchar, D. B., Matsushita, K., Mussolino, M. E., Nasir, K., O'Flaherty, M., Palaniappan, L. P., Pandey, A., Pandey, D. K., Reeves, M. J., Ritchey, M. D., Rodriguez, C. J., Roth, G. A., Rosamond, W. D., Sampson, U. K. A., Satou, G. M., Shah, S. H., Spartano, N. L., Tirschwell, D. L., Tsao, C. W., Voeks, J. H., Willey, J. Z., Wilkins, J. T., Wu, J. H., Alger, H. M., Wong, S. S., & Muntner, P. (2018). Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association. Circulation, 137(12), e67-e492. https://doi.org/10.1161/CIR.0000000000000558

U.S. Preventive Services Task Force. Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., Kubik, M., Landefeld, C. S., Mangione, C. M., Silverstein, M., Simon, M. A., Tseng, C. W., & Wong, J. B. (2018). Risk assessment for cardiovascular disease with nontraditional risk factors: U.S. Preventive Services Task Force recommendation statement. JAMA, 320(3), 272-280. https://doi.org/10.1001/jama.2018.9908

Fox, C. S., Coady, S., Sorlie, P. D., Levy, D., Meigs, J. B., D'Agostino, R. B., & Wilson, P. W. (2004). Trends in cardiovascular complications of diabetes. JAMA, 292(20), 2495-2499. https://doi.org/10.1001/jama.292.20.2495

Vasan, R. S., Sullivan, L. M., Wilson, P. W., Sempos, C. T., Sundström, J., Kannel, W. B., & Levy, D. (2005). Relative importance of borderline and elevated levels of coronary heart disease risk factors. Annals of Internal Medicine, 142(6), 393-402. https://doi.org/10.7326/0003-4819-142-6-200503150-00009

Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., & Lisheng, L. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet, 364(9438), 937-952. https://doi.org/10.1016/S0140-6736(04)16898-0

Fox, C. S., Pencina, M. J., Wilson, P. W., Paynter, N. P., Vasan, R. S., & D'Agostino, R. B. (2008). Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham Heart Study. Diabetes Care, 31(8), 1582-1584. https://doi.org/10.2337/dc08-0113

Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., Arnett, D. K., Fonarow, G. C., Ho, P. M., Lauer, M. S., Masoudi, F. A., Robertson, R. M., Roger, V., Schwamm, L. H., Sorlie, P., & Yancy, C. W. (2010). Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's strategic impact goal through 2020 and beyond. Circulation, 121(4), 586-613. https://doi.org/10.1161/CIRCULATIONAHA.109.192703

Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D'Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O'Donnell, C. J., Robinson, J. G., Schwartz, J. S., Shero, S. T., Smith, S. C., Sorlie, P., Stone, N. J., Wilson, P. W., Jordan, H. S., Nevo, L., Wnek, J., Anderson, J. L., Halperin, J. L., Albert, N. M., Bozkurt, B., Brindis, R. G., Curtis, L. H., DeMets, D., Hochman, J. S., Kovacs, R. J., Ohman, E. M., Pressler, S. J., Sellke, F. W., Shen, W. K., Smith, S. C., & Tomaselli, G. F. (2014). 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129(25 Suppl 2), S49-S73. https://doi.org/10.1161/01.cir.0000437741.48683.98

Njølstad, I., Arnesen, E., & Lund-Larsen, P. G. (1996). Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction: A 12-year follow-up of the Finnmark Study. Circulation, 93(3), 450-456. https://doi.org/10.1161/01.CIR.93.3.450

Savji, N., Rockman, C. B., Skolnick, A. H., Guo, Y., Adelman, M. A., Riles, T., & Berger, J. S. (2013). Association between advanced age and vascular disease in different arterial territories: A population database of over 3.6 million subjects. Journal of the American College of Cardiology, 61(16), 1736-1743. https://doi.org/10.1016/j.jacc.2012.11.075

Currier, J. S., Taylor, A., Boyd, F., Dezii, C. M., Kawabata, H., Burtcel, B., Maa, J. F., & Hodder, S. (2003). Coronary heart disease in HIV-infected individuals. Journal of Acquired Immune Deficiency Syndromes, 33(4), 506-512. https://doi.org/10.1097/01.qai.0000088761.69814.e5

Khouri, M. G., Douglas, P. S., Mackey, J. R., Martin, M., Scott, J. M., Scherrer-Crosbie, M., & Jones, L. W. (2012). Cancer therapy-induced cardiac toxicity in early breast cancer: Addressing the unresolved issues. Circulation, 126(23), 2749-2763. https://doi.org/10.1161/CIRCULATIONAHA.112.109696

Gerstein, H. C., Mann, J. F., Yi, Q., Zinman, B., Dinneen, S. F., Hoogwerf, B., Hallé, J. P., Young, J., Rashkow, A., Joyce, C., Nawaz, S., & Yusuf, S. (2001). Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA, 286(4), 421-426. https://doi.org/10.1001/jama.286.4.421


Refbacks

  • There are currently no refbacks.